Dr. Tarawneh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2211 Lomas Blvd NE
Albuquerque, NM 87106Phone+1 505-272-2111
Education & Training
- Washington University in St. Louis School of MedicineDementia and Behavioral Neurology, 2009 - 2011
- Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2005 - 2009
- University of Jordan Faculty of MedicineClass of 2003
Certifications & Licensure
- MO State Medical License 2009 - 2025
- NM State Medical License 2021 - 2025
- OH State Medical License 2015 - 2025
- American Board of Psychiatry and Neurology Neurology
- United Council for Neurological SubspecialtiesBehavioral Neurology and Neuropsychiatry
Publications & Presentations
PubMed
- 149 citationsDiagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.Rawan Tarawneh, Gina D'Angelo, Dan L. Crimmins, Elizabeth M. Herries, Terry A. Griest
JAMA Neurology. 2016-05-01 - 27 citationsThe gut microbiome and Alzheimer's disease: Complex and bidirectional interactions.Rawan Tarawneh, Elena Penhos
Neuroscience and Biobehavioral Reviews. 2022-10-01 - 133 citationsISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpuraX. Long Zheng, Sara K. Vesely, Spero R. Cataland, Paul Coppo, Brian Geldziler
Journal of Thrombosis and Haemostasis. 2020-10-01
Press Mentions
- New Treatments for Alzheimer’s DiseaseMarch 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: